Association Between N363S and Bcl/Polymorphisms of the Glucocorticoid Receptor Gene (NR3C1) and Glucocorticoid Side Effects During Childhood Acute Lymphoblastic Leukemia Treatment

Creative Commons License

Cihan M. K., KARABULUT H. G., KUTLAY N., ILGIN RUHİ H., Tukun A., Olcay L.

TURKISH JOURNAL OF HEMATOLOGY, cilt.34, sa.2, ss.151-158, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 34 Sayı: 2
  • Basım Tarihi: 2017
  • Doi Numarası: 10.4274/tjh.2016.0253
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.151-158
  • Anahtar Kelimeler: Acute lymphoblastic leukemia, Glucocorticoid receptor gene, BclI and N363S polymorphisms, BODY-MASS INDEX, IN-VIVO, BCLI POLYMORPHISM, MAJOR DEPRESSION, CHILDREN, DISEASE, RESISTANCE, SENSITIVITY, MUTATIONS, THERAPY
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: Glucocorticoids (GCs) are the key drugs for the treatment of pediatric acute lymphoblastic leukemia (ALL). Herein, investigation of the relationship between the N363S and Bcl / polymorphisms of the GC receptor gene (NR3C1) and the side effects of GCs during pediatric ALL therapy was aimed.